BrightSpring Health Services, Inc. 8-K

What Happened

• BrightSpring Health Services, Inc. filed an 8-K reporting that Res‑Care, Inc. (a BrightSpring subsidiary) completed the previously announced Transaction to sell certain assets, equity interests and liabilities used primarily in community living services, home‑and‑community‑based waiver programs, and intermediate care facilities to National Mentor Holdings, Inc. on March 30, 2026. The aggregate consideration at closing was $835 million, subject to customary working capital and other adjustments. The underlying Purchase Agreement was dated January 17, 2025 and was amended December 5, 2025. BrightSpring issued a related press release on March 31, 2026.

Key Details

• Closing date: March 30, 2026. Buyer: National Mentor Holdings, Inc. Purchase Agreement: Jan 17, 2025 (amended Dec 5, 2025).
• Aggregate cash consideration at closing: $835 million (subject to typical working capital and customary adjustments).
• Leadership change: Robert Barnes (President, ResCare Community Living) resigned effective at closing; no severance was paid. As consideration, BrightSpring accelerated vesting of 15,540 restricted stock units and 5,640 stock options that otherwise would have vested on Jan 25, 2027 — now vesting March 30, 2026. His resignation was not due to any disagreement with the Company.
• Financial disclosures: BrightSpring furnished unaudited pro forma condensed consolidated statements (Exhibit 99.2) reflecting the Transaction’s effects for the year ended Dec 31, 2025.

Why It Matters

• The sale is a material corporate divestiture that provides BrightSpring with roughly $835M in proceeds at closing (subject to adjustments), and will shift the company’s operational footprint by removing the Res‑Care businesses specified in the agreement.
• Investors should review the company’s pro forma financial statements (Exhibit 99.2) and the March 31, 2026 press release for details on how the Transaction affects revenue mix, assets, liabilities and reported results going forward. The filing also notes the usual forward‑looking statement cautions and points investors to the company’s SEC filings for additional risk factors.